Introduction
The double stranded RNA (dsRNA)-activated, serine/ threonine protein kinase, PKR was ®rst identi®ed as a component of interferon-inducible cellular antiviral defenses (Kerr et al., 1977; Meurs et al., 1990 Meurs et al., , 1992 Hovanessian, 1993) . Activation of PKR by viral dsRNA replicative intermediates results in the phosphorylation of the a-subunit of the eukaryotic initiation factor eIF-2. Phosphorylated eIF-2a sequesters the guanine nucleotide exchange factor, eIF-2B, whose role is to recycle the inactive eIF-2-GDP complex into its activated form eIF-2-GTP, a complex necessary to begin a new round of initiation (Farrell et al., 1977; Proud, 1995; McMillan and Williams, 1996) .
The net eect of the phosphorylation of eIF-2a is the inhibition of protein synthesis and consequently inhibition of virus production.
In addition to its well-recognized role as a regulator of translation, PKR also acts as a signaling molecule in dsRNA-and cytokine-mediated signal transduction pathways (Williams, 1995) . PKR functions in the dsRNA-dependent activation of NF-kB leading to IkB phosphorylation Maran et al., 1994) . In PKR null mice, the antiviral response induced by the synthetic dsRNA, poly(I) : poly(C) (pIC) and IFN-g was diminished (Yang et al., 1995) . In vitro studies using PKR knockout mouse embryo ®broblasts (MEFs) demonstrated that the activation by IFN-g of IRF-1 was de®cient (Kumar et al., 1997) . More recently, PKR was shown to be a mediator of stress induced apoptosis (Yeung et al., 1996; Der et al., 1997) . Apoptotic cell death in response to dsRNA, tumor necrosis factor (TNF-a) and lipopolysaccharide (LPS) were de®cient in MEFs derived from PKR knockout mice. These mutant cells were unable to induce IRF-1 or Fas in response to TNF-a, pIC or LPS .
PKR acts as a negative regulator of cell growth. The ectopic expression of wild type PKR resulted in a slow growth phenotype in yeast and a decrease in the proliferation rate of mammalian cells (Koromilas et al., 1992) . In addition, the ectopic expression of catalytically inactive mutants of PKR in NIH3T3 cells led to their transformation and subsequent formation of tumors when these cells were injected into nude mice (Koromilas et al., 1992; Meurs et al., 1993; Barber et al., 1995) . This was suggested to result from interference with the activity of wild type endogenous PKR by the overexpressed mutant protein.
In accord with this, the ectopic expression of two cellular inhibitors of PKR, p58 (Barber et al., 1994) and TAR RNA binding protein, TRBP (Benkirane et al., 1997) , also resulted in malignant transformation of cells. These studies have led to the suggestion that PKR may function as a tumor suppressor gene. However, the absence of tumors in PKR null mice suggests either compensation by other proteins or alternative functions for overexpressed PKR mutants (Yang et al., 1995) .
To investigate whether levels of PKR play a role in cell growth control, we examined regulation of PKR in the human glioblastoma cell line, T98G. We show that PKR mRNA, protein and activity levels vary during progression of the cell cycle. Although protein and RNA levels were similarly regulated, the activity pro®le of PKR was distinctly dierent. Cell lines expressing a dominant negative mutant of PKR exhibited a disturbance in the cell cycle with longer G1 transition and a 1.5 ± 2-fold fewer cells in the S phase. In addition early passage mouse embryo ®broblasts derived from mice devoid of PKR exhibited slower growth kinetics compared with the control cells. Taken together these results suggest a regulatory role for PKR during cell cycle progression.
Results

PKR is regulated during the cell cycle
T98G cells can be arrested in a G0/G1 quiescent state by either contact inhibition or serum starvation (Stein, 1979; Hannigan and Williams, 1986) . Re-incubation of serum starved cells with serum containing medium results in a synchronous progression of cells through the cycle. To investigate PKR modulation through the cell cycle, T98G cells were synchronized by serum starvation. Three days after transfer into starvation medium, the percentage of cells in G1 increased from 59 to 92% and the percentage in S and G2+M decreased from 33% and 7.5% to 6% and 2%, respectively ( Figure 1a ). This remained constant during a further three days. The serum-starved cells enriched in G1 were stimulated to enter the cycle by feeding with fresh medium containing 10% FBS and assayed for DNA content by¯uorescence cytometry. Cells entered S phase approximately 15 h after stimulation (Table 1) which was mirrored by a decrease in G1 cells. As expected, the percentage of cells in G2+M peaked at a later time (25 h after stimulation; Table 1 ). The increase in S phase correlated with an increase in DNA synthesis as shown by 3 H-thymidine labeling and autoradiography 3 H]thymidine as a measure of DNA synthesis. Cells were synchronized as in a except they were cultured on coverslips. Cell cycle entry was initiated by replacing the starvation medium with medium containing 10% FBS and 5 mCi/ml [ (Figure 1b ). There was a slow and steady increase in the number of stained nuclei in a given ®eld of view with a sharp increase at the onset of S phase about 15 h after stimulation, re¯ecting an increasing number of cells engaged in DNA synthesis (Figure 1b) .
Cells harvested at regular intervals following serum stimulation of G1-enriched T98G cells ( Figure 2a) were analysed for PKR mRNA, protein and kinase activity levels. PKR mRNA levels reached a peak in growth arrested cells, declined sharply after serum stimulation and then increased gradually prior to the onset of DNA synthesis, reaching a plateau within S phase ( Figure 2b ). In cells sampled 3 h after stimulation, PKR mRNA levels were 2.7-fold lower than in growth arrested cells. PKR protein levels steadily increased after serum restoration peaking at the G2+M boundary and declining thereafter (Figure 2c ). The expression pattern of another protein implicated in the antiviral activity of IFNs, the 2-5A-dependent endoribonuclease RNase L (Zhou et al., 1993) was dierent from that of PKR. Whereas PKR protein levels increased by ®vefold, the induction in RNase L was only twofold, peaking in early S phase and declining thereafter (Figure 2c) . Thus, the changes in PKR protein levels were speci®c. The activation state of endogenous PKR was measured in the absence of any exogenous activator by in vitro auto-and substrate phosphorylation assays. The kinase activity of PKR remained essentially unchanged in the ®rst 3 h following stimulation. As cells progressed through G1 PKR activity increased, peaking initially in early G1 and later at the G1/S boundary ( Figure 2d ). There was greater than twofold increase in PKR activity in cells harvested 15.5 h after stimulation. PKR activity declined sharply in early S phase, remaining low as cells traversed through the remainder of the cycle. These results were consistent over several experiments. In each case, PKR autophosphorylation could be further elevated by the addition of pIC (results not shown). Importantly, phosphorylation of the exogenous substrate, eIF-2a, followed the same pro®le as autophosphorylation. Thus under normal growth conditions in the absence of virus or interferon, PKR is cell cycle regulated at the level of mRNA, protein and kinase activity. Although there was a good correlation between protein and RNA levels, the protein pro®le did not correlate with activity indicating there is strict cell cycle regulation of PKR at the level of its activation.
Abrogation of PKR activity in T98G cells
To determine the signi®cance of cell cycle regulation of PKR activity, we attempted to reduce this activity by expressing the catalytically inactive mutant, PKR K296R (Hanks et al., 1988; Katze et al., 1991) in T98G cells. The Lac switch expression system (Fieck et al., 1992) was used to obtain inducible expression of the mutant protein tagged with an haemagglutinin (HA)-epitope at the N-terminus. Hygromycin resistant clones expressing the lacI repressor were selected and tested for lacI protein expression by Western blotting. A clone expressing inducible lacI (T98G lacI parental) was transfected with the mutant PKR construct. Selection in hygromycin and G418 yielded approximately 120 clones from three dierent transfection experiments. However, attempts to express the wild type protein did not lead to the isolation of any stable clones, consistent with the growth inhibitory properties of PKR. Transgene expression was determined by RT ± PCR on RNA isolated from cells induced with 5 mM IPTG using primers complementary to the DNA sequence of the HA epitope. Expression of the housekeeping gene, catalase was monitored as an internal control. Of ®ve stable mutant clones tested, three expressed the transgene (Figure 3a , clones PKR K296R 32, 33 and 36; lanes 7, 10 and 16, respectively). The mutant protein was detected by immunoprecipitation with PKR monoclonal antibody followed by Western blotting with antibodies against the HA-epitope (Figure 3b ). Functional assays were employed to determine whether the activity of wild type PKR was disrupted in the mutant expressing lines. Since we have previously shown that PKR K296R interferes with NF-kB activation by dsRNA , EMSA were employed to determine whether activation of NF-kB was disrupted in mutant expressing cells. NF-kB DNA binding activity, though undetectable in T98G cells grown under normal growth conditions (10% FBS; Figure 3d , lane 1), was highly inducible upon treatment with either dsRNA or TNF-a ( Figure 3d , lanes 2 ± 5). An initial screening of stable clones by EMSA revealed, as expected, induction of NF-kB DNA binding activity in the dsRNA treated parental cell line, LacI, which was not aected by IPTG ( Figure 3c , lanes 2 and 3). In contrast, levels of NF-kB DNA binding activity in the mutant lines in the absence of IPTG varied, likely re¯ecting variable constitutive levels of mutant PKR gene expression. This implied that in T98G cells, the Lac switch system was leaky allowing for the expression of transgene in the absence of the inducer, IPTG. Thus, in clones 34, 37 and 40 ( Figure 3c , lanes 4, 10 and 14, respectively) NF-kB DNA binding activity in the absence of IPTG was comparable to the parental cell line ( Figure 3c , lane 2) whereas in clones 32, 33 and 36 ( Figure 3c , lanes 20, 22 and 8, respectively) this activity was reduced. Although we did not observe a signi®cant eect by IPTG, in some but not all mutants, the inducible NF-kB DNA binding activity could be further reduced by treatment with IPTG ( Figure 3c , compare lanes 10 and 11; 12 and 13; 14 and 15). We therefore included IPTG in all subsequent experiments. In our initial screening by EMSA clone 35 exhibited reduced NF-kB DNA binding activity ( Figure 3c ). However, this clone was later found to have lost the transgene (Figure 3a and b) .
Although the reduction in the dsRNA dependent activation of NF-kB in the mutant clones could be attributed to the expression of mutant PKR and its interference with wild type PKR activity, it remained Serum starved cells were stimulated with medium containing 10% FBS and were processed for FACS analysis as described in Materials and methods
Cell cycle regulation of PKR M Zamanian-Daryoush et al possible that in these cell lines, NF-kB per se had been aected in a PKR-independent manner. To rule out this possibility, we treated cells with TNF-a, a PKR independent inducer of NF-kB. In the case of the mutant cells 32, 33 and 36 where dsRNA dependent induction of NF-kB had been reduced or nearly abolished, the TNF-a-induced NF-kB was comparable to controls ( Figure 3d , compare lanes 7 and 8 with 9 and 10; 17 and 18 with 19 and 20). Thus, NF-kB activation in these mutant lines was intact and the de®ciency in dsRNA signaling could be directly attributed to the disruption of wild type PKR activity. Recently, we have shown that PKR is involved in the activation of IRF-1. MEFs derived from mice devoid of PKR are unresponsive to dsRNA dependent induction of IRF-1 (Kumar et al., 1997; Der et al., 1997) . To determine if the expression of mutant PKR interfered with the activity of wild type PKR, EMSA was performed on the extracts shown in Figure 3d using an IRF-1 speci®c probe . As was the case for NF-kB, TNF-a was a better inducer of IRF-1 than dsRNA. While TNF-a-dependent induction of IRF-1 was not compromised in any of the mutants (Figure 3e) , induction of IRF-1 by dsRNA was diminished, re¯ecting the pattern observed in Figure 3d . Therefore, these clones were de®cient in their PKR-dependent dsRNA signaling pathway.
We have previously established a role for PKR in stress-induced apoptosis . To determine whether our T98G clones were aected in their ability to undergo apoptosis, the dose response for cytotoxicity in response to dsRNA or LPS was measured for parental LacI cells as compared to mutant PKR K296R clone 36 cells. For LacI cells, the ED 50 for pIC was 1 mg/ml and the ED 50 for LPS was 50 ng/ml. In contrast, clone 36 was resistant to pIC or LPS at the highest concentrations tested ( Figure  3f ).
Inhibition of PKR activity in T98G cells results in the perturbation of the cell cycle
The cell cycle pro®le of PKR activity in T98G cells suggested a potential regulatory role for PKR in G1 and at the G1/S boundary (Figure 2d ). Since we had shown that the mutant PKR K296R inhibited the signal transduction activity of PKR, it was of interest to determine whether these cell lines were in any way perturbed in their cell cycle distribution. Cell lines expressing the mutant protein, clones 32 and 36, responded to serum limitation and enriched in the G1 phase of the cycle (Figure 4a ). Although the mutant expressing cell lines (32 and 36) were able to enter S phase, transition through G1 in these cells was prolonged. For example, at T=18 h the percentage of cells in G1 in clones 32 and 36 were 50 and 48 respectively compared to 36 and 19 in the nonexpressing cell lines 18 and 35, respectively ( Figure  4a , top panel). Furthermore, there were between 1.5 ± 2-fold higher a number of cells in S phase at T=18 h in non-expressing cells (18 and 35, respectively) compared to those expressing the mutant protein (32 and 36) (Figure 4a, lower panel) . The dierences at T=18 h in the number of cells engaged in S phase in the two mutant expressing cell lines (32 and 36) correlate with the inhibition of dsRNA signaling to NF-kB (Figure 3d ), compare lanes 7 and 8 with 17 and 18). Furthermore, the activity of PKR (auto-and substrate phosphorylation) was lower in the control cell line 18 compared with clone 35 (data not shown) again correlating with the cell cycle pro®le observed (Figure 4a ). The two extreme pro®les with respect to the distribution of cells in G1 and S phase in the expressing and non-expressing cells (Figure 4a ), re¯ect the activity of PKR. Thus in clone 35 which does not express the mutant, there was 1.7-and 2.3-fold induction in auto-and substrate phosphorylation, respectively upon dsRNA treatment of cells whilst in the mutant-expressing clone 36, there was 1.1-and 0.9-fold induction, respectively (Figure 4b ). Taken together, these results indicate that in T98G cells, the activity of PKR may be required for G1 and S progression since there was a correlation between PKR activity and the number of cells in G1 and S phase.
Early passage MEFs devoid of PKR grow more slowly compared to wild type cells
The results in Figure 4 pointed to a role for PKR in cell cycle progression. These experiments were performed in T98G-derived cells in which the activity of the resident wild type PKR was reduced by the expression of a trans-dominant negative mutant PKR protein. We reasoned if PKR does indeed contribute in an active manner to cell cycle progression, we should observe a dierence in the growth rate of cells devoid of PKR protein compared to wild type cells. Accordingly we cultured mouse embryo ®broblast cells derived from PKR wild type and knockout mice and followed their proliferation over 9 days. Although cells were seeded at the same initial density, at any one time there were fewer viable cells in the PKR null cell line compared to the controls (Figure 4c ). Since these experiments were performed using early passage cells derived from individual genotyped embryos from the same litter, we conclude the dierences observed re¯ect a positive role for PKR in cell cycle progression.
Discussion
The dsRNA-dependent serine/threonine kinase, PKR, is an immediate early gene induced by type I interferons with a central role in the cellular antiviral defence mechanisms triggered by IFNs. PKR mediates these eects primarily through its ability to down regulate protein synthesis thus constraining the growth and propogation of the virus. Furthermore, PKR plays a role in cellular stress responses to dsRNA, IFN-g and LPS. To better de®ne the role of PKR in cell growth regulation, we investigated the regulation of PKR in the mammalian cell cycle. We have shown that PKR activity as determined by auto-and substrate phosphorylation oscillated in T98G cells with a peak in early G1 and a second peak at the G1/S boundary. This was followed by a sharp decline in early S phase. Importantly, these changes in PKR activity were independent of PKR protein pro®le strongly implying post translational regulation of this kinase. The activity assays performed in this study were conducted in the absence of viral infection or added activator. Thus, the tight regulation of PKR activity likely re¯ects the presence of cellular activators and inhibitors which themselves are cell cycle regulated. PKR is activated by dsRNA or ssRNA with double stranded secondary structure (Hovanessian and Galabru, 1987; Petryshyn et al., 1988; Patel et al., 1994; Carpick et al., 1997; Chu et al., 1998) . During cell cycle progression, the activation of PKR in G1 may be mediated through cellular dsRNA species arising from stem-loop secondary structures of certain mRNAs. PKR activating cellular RNAs have been reported in 3T3-F442A cells (Petryshyn et al., 1988) while Alu RNA transcripts may also regulate the activity of PKR (Chu et al., 1998) . Alternatively, PKR may be part of a kinase cascade involving cyclin dependent serine/threonine kinases (cdks) which may phosphorylate PKR thus activating it.
Several cellular inhibitors of PKR have been reported. These include an inhibitor partially puri®ed from human FL cells with an apparent M r of 160 000 (Saito and Kawakita, 1991) , a 15 KDa protein (dRF) present in 3T3-F442A cells (Judware and Petryshyn, 1992) believed to play a role in the ability of these cells to dierentiate into adipocytes (Judware and Petryshyn, 1991) and an inhibitory agent present speci®cally in ras-transformed cells (Mundschau and Faller, 1992) .
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The best characterized cellular inhibitor of PKR is P58 (Polyak et al., 1996) which itself is regulated by a cellular inhibitor, I-P58, recently identi®ed as the molecular chaperone hsp40 (Melville et al., 1997 mRNA levels were detected by RT ± PCR (30 cycles; lanes 1, 4, 7, 10, 13, 16). Detection of catalase mRNA by RT ± PCR (30 cycles) was used as a control for general RNA integrity (lanes 3, 6, 9, 12, 15, 18 and 21). Lanes labeled b served as negative control where the template for PCR was RNA used in reverse transcription. Lanes X and Z served as negative control for primer sets HA-PKR (X) and catalase (Z) where the PCR template was replaced with water. In lane Y, the primer set HA-PKR was used with the plasmid pOPRSVIHAPKR K296R as template. In lanes labeled a, b, X and Y, the primer set was HA-PKR. In lanes labeled c and Z the primer set was catalase. (b) Detection of HA-PKR K296R in T98G-derived cell lines. HA-PKR K296R protein was detected in IPTG-induced cells by immunoprecipitation for total PKR followed by Western blotting with anti-HA monoclonal antibody as described in Materials and methods. Detection of NF-kB (c and d) and IRF-1 (e) DNA binding activity in mutant cell lines. Overnight IPTG (5 mM) treated cells were stimulated with dsRNA (pIC: 100 mg/ml; c, lanes 2 ± 23, d and e, indicated as dsRNA) or TNF-a (5 ng/ml; d and e, as indicated) for 2 h. Whole cell extracts were prepared and analysed by electrophoretic mobility shift assay using the PRDII (c and d) or the hexamer (e) probe, as described in Materials and methods. Lane 1 in (c) contained the probe alone. (f) Stress-induced apoptosis in T98G cells. Cells were subjected to a serial dilution of the indicated inducers and cell viability was assessed after 24 h as described in Materials and methods Cell cycle regulation of PKR M Zamanian-Daryoush et al changed throughout the cycle with a slight increase at the G2/M boundary. However, this ®nding does not rule out P58 as a regulator of PKR activity in the cell cycle since it remains possible that P58 is regulated at the level of activity.
Orderly progression through the cell cycle depends on the activity of cyclin-dependent serine/threonine kinases (cdks). Cdk activity requires cyclin binding, depends on both positive and negative regulatory phosphorylation (Morgan, 1995; Nigg, 1995) , and can be constrained by at least two families of cdk inhibitors (cdkI) (Elledge and Harper, 1994; Sherr and Roberts, 1995) . Mitogenic stimulation of quiescent cells results in the synthesis of D-type cyclins which associate with their cdk partner, cdk4/cdk6, and exhibit kinase activity beginning in mid-G1 peaking to a maximum at G1/S transition (Sherr, 1994) . Cyclin D/cdk4/6 kinases are mainly responsible for phosphorylation and consequent inactivation of the retinoblastoma tumor suppressor protein (RB) at the G1/S boundary (Ewen et al., 1993) . This in turn results in release from RB complexes of the E2F/DP transcription factor, which drives the expression of many genes required for S phase entry (Dynlacht et al., 1994; Krek et al., 1994 Krek et al., , 1995 La Thangue, 1994; Mayol et al., 1995; Weinberg, 1995) . Cdks target E2F through the RB family of phosphoproteins, RB, p107 and p130. In T98G cells, the hyperphosphorylated forms of p130 and RB ®rst appear in mid-G1, 6 ± 8 h following serum stimulation (Mayol et al., 1995) . The peaks in PKR activity observed in our study appear in mid-G1 and early S phase. It remains to be determined whether under normal growth conditions, PKR plays a role in phosphorylation of RB family members in G1 or the E2F/DP proteins in early S phase.
PKR may also regulate protein synthesis during the cell cycle through phosphorylation of eIF-2a. It is well known that progression through the cell cycle, in particular G1, is dependent on the orderly expression of regulatory genes such as cyclins and cdkIs. Activation of PKR in G1 may selectively downregulate the synthesis of such regulatory proteins once they have served their function. An analysis of phosphorylation status of eIF-2a during cell cycle progression could address this possibility.
PKR has recently been shown to couple the antiproliferative eect of IFN to the basic cell cycle machinery. Type 1 interferons are known to mediate inhibition of c-myc expression (Einat et al., 1985; Kimchi et al., 1988) , inhibition of RB phosphorylation (Thomas et al., 1991; Resnitzky et al., 1992; Kumar and Atlas, 1992; Burke et al., 1992) , reduction of cyclin a Cell cycle regulation of PKR M Zamanian-Daryoush et al A levels (Thomas et al., 1991; Resnitzky et al., 1992; Kumar and Atlas, 1992; Burke et al., 1992; Bybee and Thomas, 1992) , suppression of E2F DNA binding activity (Melamed et al., 1993; Iwase et al., 1997) , induction of the cdk inhibitor p21 (Subramanian and Johnson, 1997) , and suppression of cyclin D3 and cdc25A genes (Tiefenbrun et al., 1996) . The ectopic expression of two catalytically inactive mutants of PKR in mouse M1 myeloid leukemia cells interfered with IFN-induced suppression of c-myc protein without aecting IFN-induced RB de-phosphorylation or cyclin D/A protein levels (Raveh et al., 1996) . These results imply that although PKR may not mediate phosphorylation of RB during IFN treatment, it does, however, play a role in the IFN-mediated suppression of c-myc, possibly through inhibition of E2F activity. Figure 4 Expression of mutant PKR results in fewer cells in S phase. (a) Cell cycle pro®le of mutant cells. T98G derived stable cell lines transfected with PKR K296R expression plasmid were analysed by FACS for their cell cycle pro®le following cell synchronization in G1 and subsequent serum stimulation as described in Materials and methods. (b) PKR activity in mutant cells. IPTG stimulated cells (5 mM, overnight) were treated with dsRNA (pIC: 100 mg/ml) for 2 h and extracts prepared in IP lysis buer as described in Materials and methods. PKR was immunopuri®ed from 100 mg of extract and subjected to in vitro kinase assays in the presence of histone as described in Materials and methods. (c) MEF growth curve studies. Passage 2 primary mouse embryo ®broblasts from individual embryos were analysed for their growth properties as described in Materials and methods It would be intriguing to determine whether PKR can phosphorylate E2F/DP1 since the activity of PKR peaks in early S phase when E2F is downregulated.
b c
PKR has been studied primarily in the context of IFN induction and viral infection. The antiproliferative function of PKR was determined through overexpression of the wild type kinase Koromilas et al., 1992) . The approach taken in this report contrasts the approaches taken in previous studies in that the focus of study was PKR at its physiological level in the absence of any IFN or virus. In this study, we have shown a tight cell cycle regulation of PKR activity in T98G cells, suggesting a role for PKR in cell cycle control. We investigated this possibility through ectopic expression of the dominant negative mutant, PKR K296R . Despite the fact that the abrogation of the wild type PKR activity was not complete in the mutant expressing cell lines ( Figure  3b ± d) , nevertheless, the level of inhibition was sucient to interfere with two established activities of PKR: signaling in response to dsRNA and stress induced apoptosis as well as disturbing cell cycle distribution. The PKR K296R mutant expressing cell lines which had lower PKR activity exhibited a longer G1 transition and fewer cells engaged in S phase. There was a direct correlation between the activity of PKR and the altered cell cycle pro®le. Furthermore, mouse embryo ®broblasts devoid of PKR exhibited a slower kinetics of growth compared to control cells, supporting the results obtained in the human glioblastoma cell line. The implications of these observations are that PKR contributes to cell cycle progression, however, the mechanism remains to be determined.
Materials and methods
Cell culture and treatments
T98G human glioblastoma cells (ATCC CRL 1690) and T98G-derived cell lines were grown in high glucose Dulbecco's modi®ed Eagles's medium (Gibco) supplemented with 10% (vol/vol) heat-inactivated foetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin (complete growth medium). The stable cell lines were maintained in medium containing 200 mg/ml hygromycin (LacI, and PKR K296R clones) and 400 mg/ml G418 (PKR K296R clones). For G0/G1 synchronization by serum limitation, asynchronous cultures at approximately 80% con¯uence were washed with phosphate-buered saline and placed in DMEM containing 0.1 ± 0.5% (vol/vol) FBS for 3 days. Cells were stimulated to enter the cycle by switching into complete growth medium. T98G-derived cell lines were treated overnight with 5 mM IPTG prior to stimulation with complete growth medium containing IPTG.
Plasmids
The in¯uenza virus haemagglutinin (HA) epitope tagged mutant PKR (HA-PKR K296R ) was initially constructed in pBKS (Stratagene). A single copy of the HA oligonucleotide (sense strand: 5'-AGC TTC ACC ATG GCT TAC CCA TAC GAT GTT CCA GAT TAC GCT AGC TTG AG; antisense: 5'-GAT CCT CAA GCT AGC GTA ATC TGG AAC ATC GTA TGG GTA AGC CAT GGT GA) was cloned as a 5'-HindIII ± BamHI-3' fragment into pBKS (pBSHA). The HA oligo nucleotide contains a unique NheI site at the 3'-end. The polymerase chain reaction was used to clone the sequence encoding the catalytically inactive PKR (PKR K296R ) in which the invariant lysine-296 has been mutated into arginine, as an 5'-NheI ± NotI-3' fragment downstream and in frame with the HA epitope in pBSHA. The linker XhoI ± NotI ± HindIII was next cloned upstream of the HA epitope. The expression of the resulting 1.5 Kb insert was tested in an in vitro transcription-translation system (Promega). HA-PKR K296R cDNA was excised as a NotI fragment and cloned into pOPRSVICAT (Stratagene), replacing the CAT gene (pOPRSVIHAPKR K296R ). p3'SS and pOPRSVICAT are components of the Lac switch system (Stratagene).
Construction of stable cell lines
Stable cell lines were derived from T98G cells following lipofectamine (Gibco) transfection in two stages. The parental cell line, LacI, was ®rst obtained by transfecting T98G cells with the lacI expression plasmid, p3'SS. Cells were selected in medium containing 200 mg/ml of hygromycin B (Sigma). Monoclonal lines were isolated 3 weeks after selection. Individual lines were screened for the expression of lacI protein by Western blotting using polyclonal antibody against lacI (Stratagene). One expressing clone was used for the second round of transfection with pOPRSVIHAPKR K296R . Transfected cells were transferred into selection medium (hygromycin B and G418, 200 mg/ml of each) within 3 days. G418 concentration was gradually increased to 400 mg/ml over the next 8 days. Within 3 weeks of selection, monoclonal cell lines were isolated and checked for the expression of HA-PKR K296R by RT ± PCR.
Cell cycle analysis
Cell cycle distribution was determined by staining DNA with propidium iodide and subjecting cells to¯uorescence activated cell sorting (FACS) analysis. For [ 3 H]thymidine incorporation experiments, cells were grown on cover slips and synchronized as above.
[ 3 H]thymidine was included (5 mCi/ml; 84.6 Ci/mmol) in the stimulation medium. Cells were ®xed at indicated times by ®rst washing in PBS and then incubating for 5 min in 100% methanol. Samples were next washed with PBS and water, dried and then exposed to NTB-2 emulsion (Kodak) for 72 h at 48C before developing with D19 developer (Kodak) according to the manufacturer's instructions.
MEF growth studies
For growth curve studies, passage two primary mouse embryo ®broblasts (MEFs) were used. The latter were derived from individual genotyped embryos from the same litter obtained from a cross of 129sv mice heterozygous for the PKR deleted allele. Cells were seeded in six well tissue culture dishes at a cell density of 10 5 per 3 ml per well in DMEM supplemented with 10% FBS and antibiotics. Cells were fed with fresh medium every day. Viable cell counts were made using trypan blue in triplicates as indicated in Figure 4c .
Preparation of cell lysates and Western blotting
Frozen T98G cell pellets were thawed on ice, resuspended in mammalian lysis buer (20 mM Tris-HCl, pH 7.0, 150 mM NaCl, 10% (vol/vol) glycerol, 1% (vol/vol) Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 100 mM NaF, 10 mM sodium pyrophosphate, 1 mM PMSF and 10 mg/ml each of aprotinin and leupeptin), stored on ice for 20 min before clari®cation by centrifugation (18 000 g, 20 min, 48C). For T98G-derived cell lines, fresh cell pellets were resuspended in immunoprecipitation lysis buer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 10% (vol/vol) glycerol, 1% (vol/vol) NP-40, 5 mM EDTA, 1 mM DTT, 100 mM NaF, 2 mM sodium pyrophosphate, 2 mM sodium orthovanadate and protease inhibitors as above) and processed as for T98G extracts. Western blotting for PKR was performed on 20 mg protein using a polyclonal rabbit antiserum raised against human PKR. Detection was by enhanced chemiluminescence (Amersham) following the manufacturer's protocol. PKR bands were quantitated by densitometry. To detect HA-PKR K296R , overnight IPTG (5 mM) induced cells were lysed in buer I (20 mM Tris-HCl, pH 7.6, 50 mM KCl, 400 mM NaCl, 1 mM EDTA, 1% (vol/vol) Triton X-100, 10 mg/ml aprotinin, 0.2 mM PMSF, 20% (vol/vol) glycerol, 5 mM 2-mercaptoethanol, 50 mM NaF and 1 mM sodium orthovanadate) and 800 mg protein used for immunoprecipitation with anti-PKR monoclonal antibody. The immunoprecipitates were subjected to Western blotting using 7.5% SDS ± PAGE and monoclonal antibody against the HA-epitope (12CA5 clone; Boehringer Mannheim).
RNase protection assay
Total RNA was prepared from 5610 6 T98G cells using RNazol (Tel-Test) following the manufacturer's instructions. PKR antisense RNA probe was prepared as previously described (Maran et al., 1994) . RNase protection assay was performed using Boehringer Mannheim kit. Brie¯y, hybridization was performed overnight at 448C using 3610 5 c.p.m. per reaction. A g-actin probe was included as internal control (5610 4 c.p.m.). Hybridized RNA was digested and puri®ed according to manufacturer's instructions and run on a 6% polyacrylamide/7 M urea gel. The PKR and g-actin protected bands (409 and 228 bp, respectively) were quantitated by phosphorimager (Molecular Dynamics).
PKR activity assays
PKR was immunopuri®ed from 100 ± 200 mg lysate using monoclonal antibody (Mab) speci®c for human PKR (Galabru and Hovanessian, 1985) . Following a 3 h incubation at 48C with Mab-protein G-sepharose, the bound kinase was ®rst washed twice with lysis buer followed by DBGA (10 mM Tris-HCl, pH 7.6, 50 mM KCl, 2 mM magnesium acetate, 20% (vol/vol) glycerol, 7 mM mercaptoethanol) before incubation (20 min at 308C) in DBGA containing 0.83 mM manganese chloride, 0.8 mM ATP, 120 ng of puri®ed eIF-2a (a kind gift from Dr B Merrick at Case Western University) and 9 mCi of [g-32 P]ATP. Where indicated, 500 ng histone protein (Sigma) was used instead of eIF-2a. The reaction was stopped by the addition of 26SDS ± PAGE sample buer. Phospho-proteins were resolved on 10 ± 12.5% SDS ± PAGE gels and quantitated by phosphorimager.
Electrophoretic mobility shift assay
Cells (1610 6 per 10 cm dish) were grown for 24 h before treatment overnight with 5 mM IPTG. Cells were washed twice with warm PBS and treated with various inducers. The induction medium was serum-free containing 5 mM IPTG. Cells were treated for 2 to 3 h with 100 mg/ml poly(I).poly(C) (pIC; Sigma) or 5 ng/ml TNF-a (Boehringer Mannheim). Cells were washed with cold PBS and scraped in the same buer. Cell pellets were resuspended in extraction buer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1.5 mM MgCl 2 , 1% (vol/vol) Triton X-100, 10% (vol/vol) glycerol) and incubated on ice for 20 min. The samples were cleared by centrifugation 18 000 g, 20 min, 48C), and the supernatants, representing whole cell extracts, were collected. Extracts (20 mg protein) were incubated in binding buer (8 mM HEPES, pH 7.0, 10% (vol/vol) glycerol, 20 mM KCl, 4 mM MgCl 2 , 1 mM sodium pyrophosphate) containing 1 mg poly(dI).poly(dC) and 32 P-end-labeled probes (3610 5 c.p.m. per reaction) for 20 min at room temperature. The detection probe for NF-kB was the PRDII regulatory element from the IFN-b promoter (position 755 to 766). IRF-1 was detected using four tandem copies of the hexamer element (AAGTGA) from the Gbp-2 promoter (position 749 to 754). The mixtures were analysed by electrophoresis using 6% polyacrylamide/Tris-glycine gels. The dried gels were subjected to autoradiography.
Reverse transcription-PCR
Total RNA (1 mg) was reverse transcribed using poly(dT) primer and Superscript II reverse transcriptase (Gibco) in 25 ml of 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 1 mM dNTPs. PCR was performed on 2 ml aliquots from each cDNA reaction, using primer sets for detecting HA-PKR K296R , approximately 300 bp, (5'-GGCTTACCCATACGATGTTCCAG, 5'-GATCAG-GCCTATGTAATTCCCCATGGATAAT) or catalase, approximately 500 bp, (5'-AGTGGCCAACTACCAGCG-TGATGG, 5'-TCCAGTGATGAGCGGGTTACACG).
Apoptosis assays
Parental T98G cells or the dierent stable transformation were plated at 50 000 cells per well in 96-well tissue culture plates and incubated at 378C overnight. Initial stocks of pIC (100 mg/ml) and LPS (1.0 mg/ml) were made using media and then serial dilutions of these were prepared using media containing actinomycin D (1.0 mg/ml). These dilution series were transferred onto the T98G cells and after 24 h incubation, viable cells remaining on the plates were stained with crystal violet (0.5% in PBS). The plates were read on a microplate reader to determine the median eective dose for cytotoxicity.
